Chip Diagnostics - About the company
Chip Diagnostics is a seed company based in Philadelphia (United States), founded in 2016 by David Issadore. It operates as a Penn Center for Innovation: University of Pennsylvania's tech transfer and venture arm. Chip Diagnostics has raised $250K in funding. The company has 99 active competitors, including 29 funded and 15 that have exited. Its top competitors include companies like Biological Dynamics, Fluidic Analytics and Oncobit.
Company Details
Penn Center for Innovation: University of Pennsylvania's tech transfer and venture arm, fostering innovation and entrepreneurship. It commercializes groundbreaking technologies, supports startups, and connects researchers with industry partners. The center facilitates technology licensing, corporate alliances, and sponsored research. It aids inventors in disclosing inventions and guides entrepreneurs through the startup journey. It also offers resources for navigating the entrepreneurial ecosystem. The center supports ventures across digital health, diagnostics, advanced materials, therapeutics, and medical devices. It aims to translate research into real-world impact, driving economic development and societal benefit. It also provides resources for faculty forming new ventures, and connects investors with promising companies based on university technology.
Key Metrics
Founded Year
2016
Location
Philadelphia, United States
Stage
Seed
Total Funding
$250K in 1 round
Latest Funding Round
Investors
Ranked
61st among 99 active competitors
Employee Count
9 as on Jul 01, 2024
Similar Companies
Legal entities associated with Chip Diagnostics
Chip Diagnostics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CHIP Diagnostics, Inc. CIN: 475590543 , United States, Active | - | - | - |
Sign up to download Chip Diagnostics' company profile
Chip Diagnostics's funding and investors
Chip Diagnostics has raised a total funding of $250K over 1 round. Chip Diagnostics has 1 institutional investor.
Here is the list of recent funding rounds of Chip Diagnostics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 08, 2016 | 2893394 | Seed | 2442416 | 5382084 | 2706916 | 1952409 |
View details of Chip Diagnostics's funding rounds and investors
Chip Diagnostics' founders and board of directors
Founder? Claim ProfileThe founders of Chip Diagnostics is David Issadore.
Here are the details of Chip Diagnostics' key team members:
- David Issadore: Founder of Chip Diagnostics.
View details of Chip Diagnostics's Founder profiles and Board Members
Chip Diagnostics' employee count trend
Chip Diagnostics has 9 employees as of Jul 24. Here is Chip Diagnostics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Chip Diagnostics's Competitors and alternates
Top competitors of Chip Diagnostics include Biological Dynamics, Fluidic Analytics and Oncobit. Here is the list of Top 10 competitors of Chip Diagnostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Biological Dynamics 2010, San Diego (United States), Series C | Provider of molecular diagnostics plaform | $67.6M | 57/100 | |
2nd | Fluidic Analytics 2013, Cambridge (United Kingdom), Series C | Develops microfluidic-based tools for protein characterization | $40.5M | 54/100 | |
3rd | Oncobit 2018, Zurich (Switzerland), Series A | Developer of diagnostic and monitoring tests for precision treatment | $6.58M | 52/100 | |
4th | Miroculus 2014, San Francisco (United States), Acquired | Developer of MicroRNA profiling platform to detect genes in the sample | $48.4M | 50/100 | |
5th | Genedrive 2000, Manchester (United Kingdom), Public | Provider of point of care molecular diagnostics platform for genotyping and sequence analysis | - | 49/100 | |
6th | C3J Therapeutics 2006, Los Angeles (United States), Series D | Developing phage therapeutics to combat antibiotic-resistant bacterial infections | $154M | 48/100 | |
7th | Molecular Designs 2019, Birmingham (United States), Funding Raised | Developer of molecular diagnostic kits for the detection of a wide range of diseases | - | 46/100 | |
8th | InDex Pharmaceuticals 2000, Stockholm (Sweden), Public | DNA-based immunomodulatory sequence medication for the treatment of inflammtatory bowel disease. | $45.4M | 46/100 | |
9th | Precision Nanosystems 2010, Vancouver (Canada), Acquired | Manufactures instruments, kits, and reagents for nanomedicine development | $25.4M | 44/100 | |
10th | IDEX Health & Science 2002, Rohnert Park (United States), Unfunded | Optofluidic and optical solutions for life science and health industries | - | - | 44/100 |
61st | Chip Diagnostics 2016, Philadelphia (United States), Seed | Penn Center for Innovation: University of Pennsylvania's tech transfer and venture arm | $250K | 26/100 |
Looking for more details on Chip Diagnostics's competitors? Click here to see the top ones
Chip Diagnostics's Investments and acquisitions
Chip Diagnostics has made no investments or acquisitions yet.
Reports related to Chip Diagnostics
Here is the latest report on Chip Diagnostics's sector:
Are you a Founder ?
FAQs about Chip Diagnostics
Explore our recently published companies
- Professionalaffiliates - 2009 founded, Unfunded company
- Hki - Unfunded company
- Leviusmedical - 2016 founded, Unfunded company
- Digitalstructuresgroup - Unfunded company
- Phxcomputeracademy - 2009 founded, Unfunded company
- HexaShield - India based, 2026 founded, Unfunded company